PRTG Projected Dividend Yield
Shs (New)/Portage Biotech Inc ( NASDAQ : PRTG )Portage Biotech Inc. is a clinical-stage immuno-oncology company. Co. is engaged in advancing therapies to improve long-term treatment response, and quality of life in patients with cancers. Co.'s access to technologies coupled with biological mechanisms enables the identification of clinical therapies and product development strategies, which accelerate these medicines through the translational pipeline. Co.'s portfolio consists of four platforms, with lead programs consisting of invariant natural killer T-cell (iNKT) engagers and a suite of treatments targeting the adenosine pathway. 20 YEAR PERFORMANCE RESULTS |
PRTG Dividend History Detail PRTG Dividend News PRTG Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |